Major pharmaceutical companies are directing billions of dollars toward developing 'protein degrader' drugs, a class of medicines designed to eliminate disease-causing proteins inside cells that have traditionally been difficult to target with conventional treatments. Early-stage research suggests these drugs can effectively break down proteins previously considered 'undruggable' using standard small-molecule or antibody approaches.
wsj.com
· 2026-10-15
A systematic review published by Cochrane found that doctors who received free meals and other perks from pharmaceutical companies prescribed the promoted drugs more often than those who did not. The study identified a 'dose-response' pattern, meaning prescription rates rose in step with the number of meals or gifts a doctor received.
gizmodo.com
· 2026-10-09
Nicole Saphier, a former Fox News contributor and Trump's third nominee for Surgeon General this term, has disclosed personal investments spanning technology, tobacco, fast food and pharmaceutical companies. The disclosure comes as her nomination heads toward Senate consideration after two earlier picks for the post fell through.
gizmodo.com
· 2026-09-11